Development of posiphen, an inhibitor of phosphorylated TAU expression, as a treatment of TBI
Ended Cooperative Agreement Awarded Last action
- Award ID
- W81XWH1320092
- Recipient
-
Annovis Bio Inc. UEI LS3NJ5K64FH8
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,223,102
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Funding agency
- Department of Defense
- Place of performance
- Berwyn, PA, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$236,428 | |
| Amendment | $0 | |
| Original award | $1,459,530 |
Quick answers
Who received award W81XWH1320092?
W81XWH1320092 was awarded to Annovis Bio Inc. by Medical Command (Department of the Army) on September 30, 2013.
How much is award W81XWH1320092 worth?
$1,223,102 has been obligated on W81XWH1320092.
Which agency awarded W81XWH1320092?
Medical Command (Department of the Army) awarded W81XWH1320092, with funding from Department of Defense.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award